Cargando…
Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
Recombinant antithrombin gamma (rAT) is reported as an effective drug for patients with disseminated intravascular coagulation (DIC) in Japan. As the appropriate dose and targeted AT activity remain unknown, this study aimed to determine these aspects for sepsis-induced DIC. Thirty-one patients with...
Autores principales: | Akahoshi, Tomohiko, Kaku, Noriyuki, Shono, Yuji, Yamamoto, Yuzo, Takahashi, Keita, Iyonaga, Takeshi, Momii, Kenta, Nishihara, Masaaki, Maki, Jun, Tokuda, Kentaro, Yamaura, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676283/ https://www.ncbi.nlm.nih.gov/pubmed/36380520 http://dx.doi.org/10.1177/10760296221135790 |
Ejemplares similares
-
Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Murao, Atsushi, et al.
Publicado: (2022) -
A Suggested Link Between Antithrombin Dose and Rate of Recovery from
Disseminated Intravascular Coagulation in Patients with Severe Organ
Failure
por: Kuroda, Hiromitsu, et al.
Publicado: (2022) -
Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?
por: Seam, Nitin, et al.
Publicado: (2014) -
Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017) -
Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
por: Wada, Takeshi, et al.
Publicado: (2022)